Coronary-artery revascularization before elective major vascular surgery

By E. McFalls, H. Ward, Thomas E. Moritz, S. Goldman, W. Krupski, F. Littooy, G. Pierpont, S. Santilli, J. Rapp, B. Hattler and 6 more. 2005

1,131 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Physiology, Urology

View Paper: https://www.semanticscholar.org/paper/1a094b4106ee872b08928c032e58bd03b37bc465

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Chaikof
2. W. Hiatt
3. R. Dalman
4. L. Norgren
5. D. Brewster
6. M. Makaroun
7. K. Illig
8. M. Eskandari

Citations in the corpus

• ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007, background): “The first large, randomized trial (Coronary Artery Revascularization Prophylaxis [CARP]) was published by McFalls and colleagues (38), who randomly assigned 510 patients with significant coronary artery stenosis from among 5859 patients scheduled for vascular operations to either coronary artery rev”
• The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018, background): “among patients undergoing elective vascular surgery.(96,97) Coronary revascularization is indicated for acute”
• KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. (2020, result): “The Coronary Artery Revascularization Prophylaxis (CARP) trial randomly assigned over 500 patients with stable CAD requiring elective vascular surgery to either medical therapy alone or medical therapy plus revascularization and found no difference in mortality between the two groups.(414) Similar f”
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). (2007, background): “However in the recent Coronary Artery Revascularization Prophylaxis (CARP) trial of patients with peripheral vascular disease who were considered high risk for perioperative complications and had significant CAD, coronary revascularization did not reduce overall mortality or perioperative myocardial”
• Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. (2017, methodology): “71 This trial randomized 510 patients with known signi fi cant coronary artery disease to preoperative coronary revascularization vs no coronary revascularization before vascular surgery.”